Report cover image

Novozymes AS - Strategic SWOT Analysis Review

Publisher GlobalData
Published Apr 29, 2024
Length 48 Pages
SKU # GBDT18743798

Description

Novozymes AS - Strategic SWOT Analysis Review


- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Novozymes AS (Novozymes) is a biotechnology company, which produces and sells industrial enzymes and microorganisms. The company provides enzymes for detergents, and technical, food, and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning, and wastewater treatment; and bio innovation solutions to minimize CO2 emissions. Novozymes’s products also find application in hand and automatic dishwashing soaps, laundry detergents, and professional cleaning products. It also conducts R&D, production, sale, and marketing operations through its subsidiaries. The company has an operational presence spanning Europe, the Middle East, Africa, North America, Asia-Pacific, and Latin America. Novozymes is headquartered in Bagsvaerd, Denmark.
Novozymes AS Key Recent Developments

Feb 01,2024: Legacy Novozymes Delivers Solid Last Full-Year Results
Jan 26,2024: All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen
Oct 26,2023: Novozymes Announces Interim Report for 9M 2023
Oct 10,2023: Executive Leadership Team and Organizational Structure Announced for the Future Combined Company of Novozymes and Chr. Hansen

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.

Table of Contents

48 Pages
Section 1 - About the Company
Novozymes AS - Key Facts
Novozymes AS - Key Employees
Novozymes AS - Key Employee Biographies
Novozymes AS - Major Products and Services
Novozymes AS - History
Novozymes AS - Company Statement
Novozymes AS - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Novozymes AS - Business Description
Business Segment: Agriculture, Animal Health & Nutrition
Overview
Performance
Business Segment: Bioenergy
Overview
Performance
Business Segment: Food, Beverages and Human Health
Overview
Performance
Business Segment: Grain and Tech Processing
Overview
Performance
Business Segment: Household Care
Overview
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Denmark
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: North America
Performance
Geographical Segment: Rest of Europe, Middle-East and Africa
Performance
R&D Overview
Novozymes AS - Corporate Strategy
Novozymes AS - SWOT Analysis
SWOT Analysis - Overview
Novozymes AS - Strengths
Novozymes AS - Weaknesses
Novozymes AS - Opportunities
Novozymes AS - Threats
Novozymes AS - Key Competitors
Section 3 – Company’s Lifesciences, Power Financial Deals and Alliances
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Novozymes AS, Recent Deals Summary
Section 4 – Company’s Recent Developments
Feb 01, 2024: Legacy Novozymes Delivers Solid Last Full-Year Results
Jan 26, 2024: All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen
Oct 26, 2023: Novozymes Announces Interim Report for 9M 2023
Oct 10, 2023: Executive Leadership Team and Organizational Structure Announced for the Future Combined Company of Novozymes and Chr. Hansen
Aug 09, 2023: Novozymes delivers results within expectations in the first half of 2023 and narrows the full year outlook
May 22, 2023: Novozymes oneHealth presence felt at 2023 China Gut Conference, featuring the theme, Innovation, Collaboration, Symbiosis
Mar 30, 2023: Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner
Mar 02, 2023: Novozymes Announces Resolutions of Annual Shareholders’ Meeting 2023
Feb 03, 2023: Novozymes' Invitation to annual shareholders' meeting 2023
Jan 26, 2023: Novozymes delivers historically strong full-year results
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Novozymes AS, Key Facts
Novozymes AS, Key Employees
Novozymes AS, Key Employee Biographies
Novozymes AS, Major Products and Services
Novozymes AS, History
Novozymes AS, Subsidiaries
Novozymes AS, Key Competitors
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Novozymes AS, Recent Deals Summary
List of Figures
Novozymes AS, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Novozymes AS, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us